what is glp 1 agonist drugs Top GLP-1 Agonists Balance Weight Loss Efficacy, Safety GLP-1 receptor agonists – How
Description
Nonfatal stroke is a leading cause of disability worldwide, with high costs of medical care and a major impact on patients quality of life [63]
doi: 10.1016/0014-5793(72)80418-6
Weight Loss: Average weight loss in the LEAD trials was 2 kg to 3.24 kg, with the majority of the reduction noted in the first 4 months of therapy, but tending to be sustained throughout the remaining period of the studies
doi: 10.1210/jc.2010-2822
In the T2D trial, WL was lower than in the obesity trial however the trial duration was shorter (36 weeks) [46]
